Alza
(Redirected from
ALZA
)This article contains content that is written like an advertisement. (March 2023) |
Parent | Johnson & Johnson |
Alza Corporation was an American
medical systems company.[1]
Background
Founded in 1968 by Dr.
portmanteau of his name. Alza was a major pioneer in the field of drug delivery systems, bringing over 20 prescription pharmaceutical products to market, and employing about 10,000 people during 20 years.[citation needed] In 2001, Alza was acquired by Johnson & Johnson via a stock-for-stock transaction worth US$10.5 billion.[2]
Drug delivery platforms
The company owns the patents on the following delivery platforms:
- Alzamer Depot
- D-Trans
- DUROS implant
- E-Trans electrotransport
- Macroflux transdermal system
- Stealth liposomal
Marketed Alza products
- Catapres-TTS – now marketed by Janssen Pharmaceuticals
- Concerta – now marketed by Janssen Pharmaceuticals
- G.D. Searle
- Ditropan XL
- Duragesic
- Doxil
- Jurnista / Exalgo
- Glucotrol XL – with Pfizer
- Nicoderm CQ
- Procardia XL– with Pfizer
- Efidac/24 – marketed by CIBA Consumer Pharmaceuticals[4]
- Spirolactone
- Viadur – licensed to Bayer after approval in 2000,[5] but marketing was discontinued in 2008[6]
Locations
Alza built its first
Palo Alto, California. In 1990, Alza moved its headquarters to Shoreline Business Park, where it remained until late 2007, a few years after Alza was acquired by Johnson & Johnson.[7][8] The remaining employees were relocated to two buildings elsewhere in the Shoreline Business Park.[citation needed
]
Alza operated a large-scale manufacturing facility in
Google's Googleplex is located just east of Alza Plaza. In August–September 2008, Google moved into the Alza plaza buildings.
See also
References
- ^ "ALZA Corp. faces layoffs in Vacaville". The Vacaville Reporter. 4 November 2009. Retrieved 4 September 2023.
- ^ "Johnson & Johnson to Merge With Alza Corporation In $10.5 Billion Stock-for-Stock Transaction" (Press release). New Brunswick, New Jersey, and Mountain View, California: Johnson & Johnson. Johnson & Johnson. 27 March 2001. Archived from the original on 11 July 2015. Retrieved 10 July 2015.
- ^ Gareth Macdonald (28 April 2009). "Patheon to make Oros-based depression and allergy drugs". Decision News Media SAS.
- ^ Center for Drug Evaluation and Research (9 May 1995). "Approval Package For: Application Number: NDA 20-021/S-003" (PDF). Retrieved 10 July 2015.
- ^ "Bayer to Market Alza's Viadur(TM) in U.S." (Press release). MOUNTAIN VIEW, Calif., and WEST HAVEN, Conn.: PRNewswire. PRNewswire. 5 April 2000. Retrieved 10 July 2015.
- ^ "Marketing of Viadur(R) (leuprolide acetate implant) to Phase Out by April 2008" (Press release). WAYNE, N.J.: PRNewswire. PRNewswire. 20 December 2007. Retrieved 10 July 2015.
- ^ Simonson, Sharon (26 August 2007). "Alza's exit could mean another office space buy for Google – Silicon Valley/San Jose Business Journal". Sanjose.bizjournals.com. Retrieved 29 July 2011.
- ^ "Alza Corp. leaving city after 17 years – Mountain View Voice". Mv-voice.com. Archived from the original on 24 July 2011. Retrieved 29 July 2011.
- ^ Palmer, Eric (2 April 2019). "Janssen laying off 4 dozen employees as California plant heads toward closure". Fierce Pharma. Archived from the original on 31 May 2019. Retrieved 21 May 2019.
- ^ "'Devastating' Jobs Blow for Cashel and Tipperary with Closure of Alza/Cordis Plant". Retrieved 7 November 2016.